Parnassus Investments’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.9M | Buy |
1,286,979
+62,220
| +5% | +$4.35M | 0.21% | 62 |
|
|
2025
Q1 | $90M | Buy |
1,224,759
+45,741
| +4% | +$3.36M | 0.22% | 67 |
|
|
2024
Q4 | $77.2M | Buy |
1,179,018
+1,171,612
| +15,820% | +$76.8M | 0.17% | 84 |
|
|
2024
Q3 | $577K | Sell |
7,406
-2,606
| -26% | -$203K | ﹤0.01% | 126 |
|
|
2024
Q2 | $781K | Buy |
10,012
+401
| +4% | +$31.3K | ﹤0.01% | 124 |
|
|
2024
Q1 | $651K | Buy |
9,611
+4,970
| +107% | +$337K | ﹤0.01% | 130 |
|
|
2023
Q4 | $313K | Buy |
4,641
+1,316
| +40% | +$88.6K | ﹤0.01% | 128 |
|
|
2023
Q3 | $225K | Sell |
3,325
-1,375
| -29% | -$93.1K | ﹤0.01% | 137 |
|
|
2023
Q2 | $336K | Sell |
4,700
-1,131
| -19% | -$80.9K | ﹤0.01% | 126 |
|
|
2023
Q1 | $405K | Buy |
5,831
+1,926
| +49% | +$134K | ﹤0.01% | 120 |
|
|
2022
Q4 | $265K | Buy |
+3,905
| New | +$265K | ﹤0.01% | 129 |
|